This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Smithkline Beecham (Cork) Ltd. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Martin Howard Osterhout: Innovator in Quinazoline Ditosylate Salt Compounds
Introduction
Martin Howard Osterhout is a notable inventor based in the United States. He has made significant contributions to the field of medicinal chemistry, particularly in the development of quinazoline ditosylate salt compounds. His work focuses on addressing disorders characterized by aberrant erbB family PTK activity.
Latest Patents
Although Martin Howard Osterhout currently holds no patents, his research on quinazoline ditosylate salt compounds is noteworthy. These compounds are described as having potential therapeutic applications in treating various medical conditions.
Career Highlights
Martin Howard Osterhout is associated with Glaxo Group Limited, a prominent pharmaceutical company. His role at Glaxo Group Limited has allowed him to engage in innovative research and development in the pharmaceutical sector.
Collaborations
Throughout his career, Martin has collaborated with esteemed colleagues, including Michael Scott McClure and Frank Roschangar. These collaborations have contributed to the advancement of research in his field.
Conclusion
Martin Howard Osterhout is an influential figure in the realm of medicinal chemistry, particularly known for his work on quinazoline ditosylate salt compounds. His contributions continue to impact the pharmaceutical industry and the treatment of various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile